{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:08:43Z","timestamp":1788754123834,"version":"build-2803163510"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p><jats:italic>Neisseria meningitidis<\/jats:italic> is an encapsulated Gram-negative diplococcus that asymptomatically colonises the upper respiratory tract in up to 25% of the population (mainly adolescents and young adults). Invasive meningococcal disease (IMD) caused by <jats:italic>Neisseria meningitidis<\/jats:italic> imposes a substantial public health burden,. The case fatality rate (CFR) of IMD remains high. IMD epidemiology varies markedly by region and over time, and there appears to be a shift in the epidemiology towards older adults. The objective of our review was to assess the published data on the epidemiology of IMD in older adults (those aged\u2009\u2265\u200955\u00a0years)in North America and Europe. Such information would assist decision-makers at national and international levels in developing future public health programmes for managing IMD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A comprehensive literature review was undertaken on 11 August 2020 across three databases: EMBASE, Medline and BIOSIS. Papers were included if they met the following criteria: full paper written in the English language; included patients aged\u2009\u2265\u200956\u00a0years; were published between 1\/1\/2009 11\/9\/2020 and included patients with either suspected or confirmed IMD or infection with <jats:italic>N. meningitidis in<\/jats:italic> North America or Europe<jats:italic>.<\/jats:italic> Case studies\/reports\/series were eligible for inclusion if they included persons in the age range of interest. Animal studies and letters to editors were excluded. In addition, the websites of international and national organisations and societies were also checked for relevant information.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were 5,364 citations identified in total, of which 76 publications were included in this review. We identified that older adults with IMD were mainly affected by serogroups W and Y, which are generally not the predominant strains in circulation in most countries. Older adults had the highest CFRs, probably linked to underlying comorbidities and more atypical presentations hindering appropriate timely management. In addition, there was some evidence of a shift in the incidence of IMD from younger to older adults.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The use of meningococcal vaccines that include coverage against serogroups W and Y in immunization programs for older adults needs to be evaluated to inform health authorities\u2019 decisions of the relative benefits of vaccination and the utility of expanding national immunization programmes to this age group.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-022-12795-9","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T11:02:56Z","timestamp":1645614176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Invasive meningococcal disease in older adults in North America and Europe: is this the time for action? A review of the literature"],"prefix":"10.1186","volume":"22","author":[{"given":"Sandra","family":"Guedes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Bertrand-Gerentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Coste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Oster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,23]]},"reference":[{"issue":"3","key":"12795_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11910-015-0524-6","volume":"15","author":"R Dwilow","year":"2015","unstructured":"Dwilow R, Fanella S. Invasive meningococcal disease in the 21st century\u2014an update for the clinician. Curr Neurol Neurosci Rep. 2015;15(3):2.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"12795_CR2","first-page":"85","volume":"7","author":"CP Hedari","year":"2014","unstructured":"Hedari CP, Khinkarly RW, Dbaibo GS. Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease. Infect Drug Resist. 2014;7:85\u201399.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"12795_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1478-7954-11-17","volume":"11","author":"RZ Jafri","year":"2013","unstructured":"Jafri RZ, Ali A, Messonnier NE, Tevi-Benissan C, Durrheim D, Eskola J, Fermon F, Klugman KP, Ramsay M, Sow S, et al. Global epidemiology of invasive meningococcal disease. Popul Health Metr. 2013;11(1):17.","journal-title":"Popul Health Metr"},{"issue":"9B","key":"12795_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1590\/0004-282X20130144","volume":"71","author":"VL Strelow","year":"2013","unstructured":"Strelow VL, Vidal JE. Invasive meningococcal disease. Arq Neuropsiquiatr. 2013;71(9B):653\u20138.","journal-title":"Arq Neuropsiquiatr"},{"issue":"1","key":"12795_CR5","first-page":"23","volume":"52","author":"NS Raja","year":"2006","unstructured":"Raja NS, Parasakthi N, Puthucheary SD, Kamarulzaman A. Invasive meningococcal disease in the University of Malaya Medical Centre, Kuala Lumpur. Malaysia J Postgrad Med. 2006;52(1):23\u20139 discussion 29.","journal-title":"Malaysia. J Postgrad Med"},{"issue":"4","key":"12795_CR6","doi-asserted-by":"publisher","first-page":"e1000396","DOI":"10.1371\/journal.ppat.1000396","volume":"5","author":"F Fransen","year":"2009","unstructured":"Fransen F, Heckenberg SGB, Hamstra HJ, Feller M, Boog CJP, van Putten JPM, van de Beek D, van der Ende A, van der Ley P. Naturally occurring lipid a mutants in Neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy. PLoS Pathog. 2009;5(4):e1000396.","journal-title":"PLoS Pathog"},{"issue":"5","key":"12795_CR7","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/aje\/kwn383","volume":"169","author":"LM Kinlin","year":"2009","unstructured":"Kinlin LM, Spain CV, Ng V, Johnson CC, White ANJ, Fisman DN. Environmental exposures and invasive meningococcal disease: an evaluation of effects on varying time scales. Am J Epidemiol. 2009;169(5):588\u201395.","journal-title":"Am J Epidemiol"},{"issue":"8","key":"12795_CR8","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1093\/cid\/civ028","volume":"60","author":"M Sadarangani","year":"2015","unstructured":"Sadarangani M, Scheifele DW, Halperin SA, Vaudry W, Le Saux N, Tsang R, Bettinger JA, investigators of the Canadian Immunization Monitoring Program A. Outcomes of invasive meningococcal disease in adults and children in Canada between 2002 and 2011: a prospective cohort study. Clin Infect Dis. 2015;60(8):e27-35.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"12795_CR9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s40273-013-0057-2","volume":"31","author":"A Anonychuk","year":"2013","unstructured":"Anonychuk A, Woo G, Vyse A, Demarteau N, Tricco AC. The cost and public health burden of invasive meningococcal disease outbreaks: a systematic review. Pharmacoeconomics. 2013;31(7):563\u201376.","journal-title":"Pharmacoeconomics"},{"issue":"37","key":"12795_CR10","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1016\/j.vaccine.2014.05.069","volume":"32","author":"BHH WangHaji Ali AfzaliMarshall","year":"2014","unstructured":"WangHaji Ali AfzaliMarshall BHH. The inpatient costs and hospital service use associated with invasive meningococcal disease in South Australian children. Vaccine. 2014;32(37):4791\u20138.","journal-title":"Vaccine"},{"issue":"10","key":"12795_CR11","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s40273-018-0679-5","volume":"36","author":"B Wang","year":"2018","unstructured":"Wang B, Santoreneos R, Afzali H, Giles L, Marshall H. Costs of invasive meningococcal disease: a global systematic review. Pharmacoeconomics. 2018;36(10):1201\u201322.","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"12795_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/INF.0000000000002251","volume":"38","author":"E Rampakakis","year":"2019","unstructured":"Rampakakis E, Vaillancourt J, Mursleen S, Sampalis JS. Healthcare resource utilization and cost of invasive meningococcal disease in Ontario Canada. Pediatr Infect Dis J. 2019;38(3):253\u20137.","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"12795_CR13","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.vaccine.2019.01.013","volume":"37","author":"S Scholz","year":"2019","unstructured":"Scholz S, Koerber F, Meszaros K, Fassbender RM, Ultsch B, Welte RR, Greiner W. The cost-of-illness for invasive meningococcal disease caused by serogroup B Neisseria meningitidis (MenB) in Germany. Vaccine. 2019;37(12):1692\u2013701.","journal-title":"Vaccine"},{"issue":"46","key":"12795_CR14","doi-asserted-by":"publisher","first-page":"6885","DOI":"10.1016\/j.vaccine.2019.09.060","volume":"37","author":"B Wang","year":"2019","unstructured":"Wang B, Haji Ali Afzali H, Giles L, Marshall H. Lifetime costs of invasive meningococcal disease: a markov model approach. Vaccine. 2019;37(46):6885\u201393.","journal-title":"Vaccine"},{"issue":"1","key":"12795_CR15","doi-asserted-by":"publisher","first-page":"e0228020","DOI":"10.1371\/journal.pone.0228020","volume":"15","author":"L Huang","year":"2020","unstructured":"Huang L, Heuer OD, Jan\u00dfen S, H\u00e4ckl D, Schmedt N. Clinical and economic burden of invasive meningococcal disease: evidence from a large German claims database. PLoS One. 2020;15(1):e0228020.","journal-title":"PLoS One"},{"issue":"4","key":"12795_CR16","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/jpids\/piv065","volume":"5","author":"L Strifler","year":"2016","unstructured":"Strifler L, Morris SK, Dang V, Tu HAT, Minhas RS, Jamieson FB, Deeks SL, Crowcroft NS, Sander B. The health burden of invasive meningococcal disease: a systematic review. J Pediatric Infect Dis Soc. 2016;5(4):417\u201330.","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"4","key":"12795_CR17","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s40121-018-0213-2","volume":"7","author":"KJ Olbrich","year":"2018","unstructured":"Olbrich KJ, M\u00fcller D, Schumacher S, Beck E, Meszaros K, Koerber F. Systematic review of invasive meningococcal disease: sequelae and quality of life impact on patients and their caregivers. Infect Dis Ther. 2018;7(4):421\u201338.","journal-title":"Infect Dis Ther"},{"key":"12795_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2147\/IDR.S12716","volume":"4","author":"M Br\u00f6ker","year":"2011","unstructured":"Br\u00f6ker M, Cooper B, Detora LM, Stoddard JJ. Critical appraisal of a quadrivalent CRM(197) conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo) in the context of treatment and prevention of invasive disease. Infect Drug Resist. 2011;4:137\u201347.","journal-title":"Infect Drug Resist"},{"issue":"2","key":"12795_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1469-0691.2005.01327.x","volume":"12","author":"E Bronska","year":"2006","unstructured":"Bronska E, Kalmusova J, Dzupova O, Maresova V, Kriz P, Benes J. Dynamics of PCR-based diagnosis in patients with invasive meningococcal disease. Clin Microbiol Infect. 2006;12(2):137\u201341.","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 1","key":"12795_CR20","first-page":"39","volume":"62","author":"A Garlicki","year":"2008","unstructured":"Garlicki A, Bociqga-Jasik M, Kalinowska-Nowak A. Invasive meningococcal disease\u2013management and treatment. Przegl Epidemiol. 2008;62(Suppl 1):39\u201344.","journal-title":"Przegl Epidemiol"},{"issue":"3","key":"12795_CR21","doi-asserted-by":"publisher","first-page":"e005027","DOI":"10.1099\/jmmcr.0.005027","volume":"3","author":"FW Nagel","year":"2016","unstructured":"Nagel FW, Ezeoke I, Antwi M, Del Rosso PE, Dorsinville M, Isaac BM, Hayden A, Hoffman RS, Weingart SD, Weiss D. Delayed recognition of fatal invasive meningococcal disease in adults. JMM Case Rep. 2016;3(3):e005027.","journal-title":"JMM Case Rep"},{"issue":"1","key":"12795_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13643-018-0747-0","volume":"7","author":"T Waterfield","year":"2018","unstructured":"Waterfield T, Fairley D, Lynn F, Blackwood B, Shields MD. A protocol for a systematic review of the diagnostic accuracy of loop-mediated-isothermal amplification (LAMP) in diagnosis of invasive meningococcal disease in children. Syst Rev. 2018;7(1):86.","journal-title":"Syst Rev"},{"key":"12795_CR23","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1017\/S0950268819002152","volume":"148","author":"C Stinson","year":"2020","unstructured":"Stinson C, Burman C, Presa J, Abalos M. Atypical presentation of invasive meningococcal disease caused by serogroup W meningococci. Epidemiol Infect. 2020;148:e12.","journal-title":"Epidemiol Infect"},{"issue":"8","key":"12795_CR24","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/cid\/ciy257","volume":"67","author":"T Guiddir","year":"2018","unstructured":"Guiddir T, Gros M, Hong E, Terrade A, Denizon M, Deghmane AE, Taha MK. Unusual initial abdominal presentations of invasive meningococcal disease. Clin Infect Dis. 2018;67(8):1220\u20137.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"12795_CR25","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1086\/379719","volume":"37","author":"P Vienne","year":"2003","unstructured":"Vienne P, Ducos-Galand M, Guiyoule A, Pires R, Giorgini D, Taha MK, Alonso JM. The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia. Clin Infect Dis. 2003;37(12):1639\u201342.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"12795_CR26","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1586\/erv.09.37","volume":"8","author":"SI Pelton","year":"2009","unstructured":"Pelton SI, Gilmet GP. Expanding prevention of invasive meningococcal disease. Expert Rev Vaccines. 2009;8(6):717\u201327.","journal-title":"Expert Rev Vaccines"},{"key":"12795_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1471-2458-9-95","volume":"9","author":"E Perea-Milla","year":"2009","unstructured":"Perea-Milla E, Olalla J, S\u00e1nchez-Cantalejo E, Martos F, Matute-Cruz P, Carmona-L\u00f3pez G, Fornieles Y, Cayuela A, Garc\u00eda-Alegr\u00eda J. ANCA Group: pre-hospital antibiotic treatment and mortality caused by invasive meningococcal disease, adjusting for indication bias. BMC Public Health. 2009;9:95.","journal-title":"BMC Public Health"},{"issue":"5","key":"12795_CR28","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1586\/erv.12.32","volume":"11","author":"V Papaevangelou","year":"2012","unstructured":"Papaevangelou V, Spyridis N. MenACWY-TT vaccine for active immunization against invasive meningococcal disease. Expert Rev Vaccines. 2012;11(5):523\u201337.","journal-title":"Expert Rev Vaccines"},{"key":"12795_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3389\/fped.2018.00321","volume":"6","author":"S Nadel","year":"2018","unstructured":"Nadel S, Ninis N. Invasive meningococcal disease in the vaccine era. Front Pediatr. 2018;6:321.","journal-title":"Front Pediatr"},{"issue":"Suppl 2","key":"12795_CR30","doi-asserted-by":"publisher","first-page":"B26","DOI":"10.1016\/j.vaccine.2011.12.032","volume":"30","author":"SA Halperin","year":"2012","unstructured":"Halperin SA, Bettinger JA, Greenwood B, Harrison LH, Jelfs J, Ladhani SN, McIntyre P, Ramsay ME, Safadi MA. The changing and dynamic epidemiology of meningococcal disease. Vaccine. 2012;30(Suppl 2):B26-36.","journal-title":"Vaccine"},{"key":"12795_CR31","doi-asserted-by":"publisher","first-page":"103571","DOI":"10.1016\/j.micpath.2019.103571","volume":"134","author":"A Purmohamad","year":"2019","unstructured":"Purmohamad A, Abasi E, Azimi T, Hosseini S, Safari H, Nasiri MJ, ImaniFooladi AA. Global estimate of Neisseria meningitidis serogroups proportion in invasive meningococcal disease: a systematic review and meta-analysis. Microb Pathog. 2019;134:103571.","journal-title":"Microb Pathog"},{"issue":"10","key":"12795_CR32","doi-asserted-by":"publisher","first-page":"e0139376","DOI":"10.1371\/journal.pone.0139376","volume":"10","author":"A Neri","year":"2015","unstructured":"Neri A, Pezzotti P, Fazio C, Vacca P, D\u2019Ancona FP, Caporali MG, Stefanelli P. Epidemiological and molecular characterization of invasive meningococcal disease in Italy, 2008\/09\u20132012\/13. PLoS One. 2015;10(10):e0139376.","journal-title":"PLoS One"},{"issue":"5","key":"12795_CR33","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/BF03405245","volume":"99","author":"T Siu","year":"2008","unstructured":"Siu T, Tang W, Dawar M, Patrick DM. Impact of routine immunization using meningococcal C conjugate vaccine on invasive meningococcal disease in British Columbia. Can J Public Health. 2008;99(5):380\u20132.","journal-title":"Can J Public Health"},{"issue":"1","key":"12795_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jinf.2012.09.008","volume":"66","author":"W Hellenbrand","year":"2013","unstructured":"Hellenbrand W, Elias J, Wichmann O, Dehnert M, Frosch M, Vogel U. Epidemiology of invasive meningococcal disease in Germany, 2002\u20132010, and impact of vaccination with meningococcal C conjugate vaccine. J Infect. 2013;66(1):48\u201356.","journal-title":"J Infect"},{"issue":"4","key":"12795_CR35","first-page":"4","volume":"4","author":"P Gunaratnam","year":"2013","unstructured":"Gunaratnam P, Massey P, Durrheim D, Torvaldsen S. Invasive meningococcal disease in elderly people, New South Wales, Australia, 1993 to 2012. Western Pac Surveill Response J. 2013;4(4):4\u201310.","journal-title":"Western Pac Surveill Response J"},{"issue":"16","key":"12795_CR36","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1016\/j.vaccine.2017.03.007","volume":"35","author":"R Whittaker","year":"2017","unstructured":"Whittaker R, Dias JG, Ramliden M, K\u00f6dm\u00f6n C, Economopoulou A, Beer N, Pastore Celentano L. ECDC network members for invasive meningococcal disease: the epidemiology of invasive meningococcal disease in EU\/EEA countries, 2004\u20132014. Vaccine. 2017;35(16):2034\u201341.","journal-title":"Vaccine"},{"issue":"2","key":"12795_CR37","first-page":"E152","volume":"61","author":"S Igidbashian","year":"2020","unstructured":"Igidbashian S, Bertizzolo L, Tognetto A, Azzari C, Bonanni P, Castiglia P, Conversano M, Esposito S, Gabutti G, Icardi G, et al. Invasive meningococcal disease in Italy: from analysis of national data to an evidence-based vaccination strategy. J Prev Med Hyg. 2020;61(2):E152\u201361.","journal-title":"J Prev Med Hyg"},{"issue":"1\u20132","key":"12795_CR38","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00508-005-0502-0","volume":"118","author":"C Berghold","year":"2006","unstructured":"Berghold C, Berghold A, F\u00fcl\u00f6p G, Heuberger S, Strauss R, Zenz W. Invasive meningococcal disease in Austria 2002: assessment of completeness of notification by comparison of two independent data sources. Wien Klin Wochenschr. 2006;118(1\u20132):31\u20135.","journal-title":"Wien Klin Wochenschr"},{"issue":"14","key":"12795_CR39","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1017\/S0950268816001308","volume":"144","author":"JA V\u00e1zquez","year":"2016","unstructured":"V\u00e1zquez JA, Taha MK, Findlow J, Gupta S, Borrow R. Global meningococcal Initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease. Epidemiol Infect. 2016;144(14):3052\u20137.","journal-title":"Epidemiol Infect"},{"issue":"1","key":"12795_CR40","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12955-019-1159-0","volume":"17","author":"O Marten","year":"2019","unstructured":"Marten O, Koerber F, Bloom D, Bullinger M, Buysse C, Christensen H, De Wals P, Dohna-Schwake C, Henneke P, Kirchner M, et al. A DELPHI study on aspects of study design to overcome knowledge gaps on the burden of disease caused by serogroup B invasive meningococcal disease. Health Qual Life Outcomes. 2019;17(1):87.","journal-title":"Health Qual Life Outcomes"},{"issue":"12","key":"12795_CR41","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S1474-4422(18)30387-9","volume":"17","author":"GBD 2016 Meningitis Collaborators","year":"2018","unstructured":"GBD 2016 Meningitis Collaborators. Global, regional, and national burden of meningitis, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(12):1061\u201382.","journal-title":"Lancet Neurol"},{"key":"12795_CR42","unstructured":"Gray S, Campbell H, Walker A, Patel S, Willerton L, Lekshmi A, Clark S, Bai X, Ribeiro S, Parikh S et al. Epidemiology and surveillance of meningococcal disease in England. 2019. https:\/\/www.meningitis.org\/getmedia\/6c45bf47-f09a-4771-87b2-8ed57fc0b67d\/Dr-Steve-Gray?disposition=attachment. Accessed 11 Nov\u00a02020. In., vol. 2020; 2019."},{"issue":"4","key":"12795_CR43","first-page":"366","volume":"51","author":"P Stefanelli","year":"2015","unstructured":"Stefanelli P, Fazio C, Neri A, Di Taranto A, Labonia M, De Robertis AL, Loconsole D, Martinelli D, Chironna M. Twenty years of surveillance of invasive meningococcal diseases in Puglia Italy. Ann Ist Super Sanita. 2015;51(4):366\u201370.","journal-title":"Ann Ist Super Sanita"},{"issue":"10","key":"12795_CR44","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1017\/S0950268817000929","volume":"145","author":"O S\u00e4ll","year":"2017","unstructured":"S\u00e4ll O, Stenmark B, Glim\u00e5ker M, Jacobsson S, M\u00f6lling P, Olc\u00e9n P, Fredlund H. Clinical presentation of invasive disease caused by Neisseria meningitidis serogroup Y in Sweden, 1995 to 2012. Epidemiol Infect. 2017;145(10):2137\u201343.","journal-title":"Epidemiol Infect"},{"issue":"5","key":"12795_CR45","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1093\/cid\/cix438","volume":"65","author":"TA Folaranmi","year":"2017","unstructured":"Folaranmi TA, Kretz CB, Kamiya H, MacNeil JR, Whaley MJ, Blain A, Antwi M, Dorsinville M, Pacilli M, Smith S, et al. Increased risk for meningococcal disease among men who have sex with men in the United States, 2012\u20132015. Clin Infect Dis. 2017;65(5):756\u201363.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"12795_CR46","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jinf.2016.07.016","volume":"73","author":"C Edge","year":"2016","unstructured":"Edge C, Waight P, Ribeiro S, Borrow R, Ramsay M, Ladhani S. Clinical diagnoses and outcomes of 4619 hospitalised cases of laboratory-confirmed invasive meningococcal disease in England: linkage analysis of multiple national databases. J Infect. 2016;73(5):427\u201336.","journal-title":"J Infect"},{"issue":"2","key":"12795_CR47","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jinf.2019.11.001","volume":"80","author":"H Campbell","year":"2020","unstructured":"Campbell H, Andrews N, Parikh S, Ribeiro S, Gray S, Lucidarme J, Ramsay ME, Borrow R, Ladhani SN. Variable clinical presentation by the main capsular groups causing invasive meningococcal disease in England. J Infect. 2020;80(2):182\u20139.","journal-title":"J Infect"},{"key":"12795_CR48","unstructured":"Ortiz de Z\u00e1rate J, Arana M, Asencor M, Mojica C, Trallero E. Epidemiology and characterization of invasive Neisseria meningitidis serogroup Y isolates in Basque country (Northern Spain) from 1995 to 2014. 2016. https:\/\/www.escmid.org\/escmid_publications\/escmid_elibrary\/material\/?mid=45891. Accessed 24 Mar\u00a02021. In., vol. 2021; 2016."},{"key":"12795_CR49","unstructured":"Parisi S, Azzari C, Bonanni P, Castiglia P, Conversano M, Icardi G, Tognetto A, Checcucci Lisi G. Invasive meningococcal diseases in Italy: an analysis of national surveillance data, 2011\u20132017. 2019. https:\/\/espidmeeting.org\/wp-content\/uploads\/sites\/21\/2019\/05\/ESPID-2019-Accepted-Abstracts-Listed.pdf. Accesssed 24 Mar\u00a02021. In., vol. 2021; 2019."},{"issue":"8","key":"12795_CR50","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1093\/cid\/civ506","volume":"61","author":"SP Stoof","year":"2015","unstructured":"Stoof SP, Rodenburg GD, Knol MJ, R\u00fcmke LW, Bovenkerk S, Berbers GAM, Spanjaard L, van der Ende A, Sanders EAM. Disease burden of invasive meningococcal disease in the Netherlands between June 1999 and June 2011: a subjective role for serogroup and clonal complex. Clin Infect Dis. 2015;61(8):1281\u201392.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"12795_CR51","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1093\/cid\/ciz578","volume":"70","author":"AD Loenenbach","year":"2020","unstructured":"Loenenbach AD, van der Ende A, de Melker HE, Sanders EAM, Knol MJ. The clinical picture and severity of invasive meningococcal disease serogroup W compared with other serogroups in the Netherlands, 2015\u20132018. Clin Infect Dis. 2020;70(10):2036\u201344.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"12795_CR52","doi-asserted-by":"publisher","first-page":"e01409","DOI":"10.1128\/JCM.01409-17","volume":"56","author":"L Eriksson","year":"2018","unstructured":"Eriksson L, Hedberg ST, Jacobsson S, Fredlund H, M\u00f6lling P, Stenmark B. Whole-genome sequencing of emerging invasive Neisseria meningitidis serogroup W in Sweden. J Clin Microbiol. 2018;56(4):e01409-01417.","journal-title":"J Clin Microbiol"},{"key":"12795_CR53","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1017\/S0950268819000396","volume":"147","author":"D Bennett","year":"2019","unstructured":"Bennett D, O\u2019Lorcain P, Morgan S, Cotter S, Cafferkey M, Cunney R. Epidemiology of two decades of invasive meningococcal disease in the Republic of Ireland: an analysis of national surveillance data on laboratory-confirmed cases from 1996 to 2016. Epidemiol Infect. 2019;147:e142.","journal-title":"Epidemiol Infect"},{"issue":"3","key":"12795_CR54","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S1473-3099(15)00430-2","volume":"16","author":"MW Bijlsma","year":"2016","unstructured":"Bijlsma MW, Brouwer MC, Kasanmoentalib ES, Kloek AT, Lucas MJ, Tanck MW, van der Ende A, van de Beek D. Community-acquired bacterial meningitis in adults in the Netherlands, 2006\u201314: a prospective cohort study. Lancet Infect Dis. 2016;16(3):339\u201347.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"12795_CR55","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1177\/003335490912400216","volume":"124","author":"C Clarke","year":"2009","unstructured":"Clarke C, Mallonee S. State-based surveillance to determine trends in meningococcal disease. Public Health Rep. 2009;124(2):280\u20137.","journal-title":"Public Health Rep"},{"issue":"12","key":"12795_CR56","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1017\/S0950268814000259","volume":"142","author":"AH Peruski","year":"2014","unstructured":"Peruski AH, Kludt P, Patel RS, DeMaria A. Secular trends in invasive meningococcal disease, Massachusetts, 1988\u20132011: what happened to invasive disease? Epidemiol Infect. 2014;142(12):2483\u201390.","journal-title":"Epidemiol Infect"},{"issue":"1","key":"12795_CR57","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4161\/hv.22302","volume":"9","author":"C Baccarini","year":"2013","unstructured":"Baccarini C, Ternouth A, Wieffer H, Vyse A. The changing epidemiology of meningococcal disease in North America 1945\u20132010. Hum Vaccin Immunother. 2013;9(1):162\u201371.","journal-title":"Hum Vaccin Immunother"},{"issue":"34","key":"12795_CR58","doi-asserted-by":"publisher","first-page":"5765","DOI":"10.1016\/j.vaccine.2011.05.089","volume":"29","author":"R Gil-Prieto","year":"2011","unstructured":"Gil-Prieto R, Garc\u00eda-Garc\u00eda L, Alvaro-Meca A, Gonz\u00e1lez-Escalada A, Viguera Ester P, De GilMiguel A. The burden of hospitalizations for meningococcal infection in Spain (1997\u20132008). Vaccine. 2011;29(34):5765\u201370.","journal-title":"Vaccine"},{"issue":"2","key":"12795_CR59","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/MD.0b013e31819d50ef","volume":"88","author":"C Cabellos","year":"2009","unstructured":"Cabellos C, Verdaguer R, Olmo M, Fern\u00e1ndez-Sab\u00e9 N, Cisnal M, Ariza J, Gudiol F, Viladrich PF. Community-acquired bacterial meningitis in elderly patients: experience over 30 years. Medicine (Baltimore). 2009;88(2):115\u20139.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"12795_CR60","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1093\/pubmed\/fdt004","volume":"35","author":"MJ Goldacre","year":"2013","unstructured":"Goldacre MJ, Maisonneuve JJ. Mortality from meningococcal disease by day of the week: english national linked database study. J Public Health (Oxf). 2013;35(3):413\u201321.","journal-title":"J Public Health (Oxf)"},{"issue":"6","key":"12795_CR61","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.jinf.2017.02.011","volume":"74","author":"I du ParentChatelet","year":"2017","unstructured":"du ParentChatelet I, Deghmane AE, Antona D, Hong E, Fonteneau L, Taha MK, Levy-Bruhl D. Characteristics and changes in invasive meningococcal disease epidemiology in France, 2006\u20132015. J Infect. 2017;74(6):564\u201374.","journal-title":"J Infect"},{"issue":"6","key":"12795_CR62","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jinf.2019.10.018","volume":"79","author":"X Bai","year":"2019","unstructured":"Bai X, Borrow R, Bukovski S, Caugant DA, Culic D, Delic S, Dinleyici EC, Eloshvili M, Erd\u0151si T, Galajeva J, et al. Prevention and control of meningococcal disease: updates from the global meningococcal initiative in Eastern Europe. J Infect. 2019;79(6):528\u201341.","journal-title":"J Infect"},{"issue":"8","key":"12795_CR63","doi-asserted-by":"publisher","first-page":"e71943","DOI":"10.1371\/journal.pone.0071943","volume":"8","author":"A Skoczy\u0144ska","year":"2013","unstructured":"Skoczy\u0144ska A, Wa\u015bko I, Kuch A, Kad\u0142ubowski M, Go\u0142\u0119biewska A, Fory\u015b M, Markowska M, Ronkiewicz P, Wasiak K, Kozi\u0144ska A, et al. A decade of invasive meningococcal disease surveillance in Poland. PloS One. 2013;8(8):e71943.","journal-title":"PloS One"},{"issue":"3","key":"12795_CR64","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jinf.2019.12.008","volume":"80","author":"K Beebeejaun","year":"2020","unstructured":"Beebeejaun K, Parikh SR, Campbell H, Gray S, Borrow R, Ramsay ME, Ladhani SN. Invasive meningococcal disease: timing and cause of death in England, 2008\u20132015. J Infect. 2020;80(3):286\u201390.","journal-title":"J Infect"},{"issue":"10","key":"12795_CR65","doi-asserted-by":"publisher","first-page":"e473","DOI":"10.1016\/S2468-2667(17)30157-3","volume":"2","author":"MJ Knol","year":"2017","unstructured":"Knol MJ, Hahn\u00e9 SJM, Lucidarme J, Campbell H, de Melker HE, Gray SJ, Borrow R, Ladhani SN, Ramsay ME, van der Ende A. Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study. Lancet Public Health. 2017;2(10):e473\u201382.","journal-title":"Lancet Public Health"},{"issue":"29","key":"12795_CR66","doi-asserted-by":"publisher","first-page":"e7573","DOI":"10.1097\/MD.0000000000007573","volume":"96","author":"V Masson-Behar","year":"2017","unstructured":"Masson-Behar V, Jacquier H, Richette P, Ziza J-M, Zeller V, Rioux C, Coustet B, Dieud\u00e9 P, Ottaviani S. Arthritis secondary to meningococcal disease: a case series of 7 patients. Medicine (Baltimore). 2017;96(29):e7573.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"12795_CR67","first-page":"S123","volume":"20","author":"M Cikirikcioglu","year":"2017","unstructured":"Cikirikcioglu M, Schrenzel J, Emonet S, Muller H, Ellenberger C, Giraud R, Kaiser L, Huber C. Keep in mind extremely rare etiologies!!! Meningococcal aortic valve endocarditis. Kardiovaskulare Medizin. 2017;20(5):S123.","journal-title":"Kardiovaskulare Medizin"},{"key":"12795_CR68","doi-asserted-by":"publisher","first-page":"e00503","DOI":"10.1016\/j.idcr.2019.e00503","volume":"15","author":"D Bajaj","year":"2019","unstructured":"Bajaj D, Agrawal A, Gandhi D, Varughese R, Gupta S, Regelmann D. Intraventricular empyema caused by Neisseria meningitidis. IDCases. 2019;15:e00503.","journal-title":"IDCases"},{"issue":"3","key":"12795_CR69","doi-asserted-by":"publisher","first-page":"253","DOI":"10.7861\/clinmedicine.18-3-253","volume":"18","author":"AJ Keeley","year":"2018","unstructured":"Keeley AJ, Hammersley D, Dhamrait SS. A case of myopericarditis caused by Neisseria meningitidis W135 serogroup with protracted inflammatory syndrome. Clin Med (Lond). 2018;18(3):253\u20135.","journal-title":"Clin Med (Lond)"},{"key":"12795_CR70","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/IMCRJ.S154807","volume":"11","author":"S Walayat","year":"2018","unstructured":"Walayat S, Hussain N, Malik AH, Vazquez-Melendez E, Aulakh BS, Lynch T. Invasive meningococcal disease without meningitis: a forgotten diagnosis. Int Med Case Rep J. 2018;11:87\u201390.","journal-title":"Int Med Case Rep J"},{"issue":"1","key":"12795_CR71","first-page":"23","volume":"5","author":"MP Romero-Gomez","year":"2012","unstructured":"Romero-Gomez MP, Rentero Z, Pa\u00f1o JR, Mingorance J. Bacteraemic pneumonia caused by Neisseria meningitidis serogroup Y. Respir Med Case Rep. 2012;5(1):23\u20134.","journal-title":"Respir Med Case Rep"},{"issue":"5","key":"12795_CR72","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1177\/1938640013501548","volume":"6","author":"D Singh","year":"2013","unstructured":"Singh D, Swann A. Skin demarcation and amputation level for foot gangrene following meningococcal septicemia. Foot Ankle Spec. 2013;6(5):384\u20138.","journal-title":"Foot Ankle Spec"},{"issue":"3","key":"12795_CR73","first-page":"179","volume":"36","author":"ME Arn\u00e1iz-Garc\u00eda","year":"2017","unstructured":"Arn\u00e1iz-Garc\u00eda ME, Arn\u00e1iz-Garc\u00eda AM, Gutierrez-Diez F, Nistal JF, Gonz\u00e1lez-Santos JM, Pulitani I, Amado-Diago C, Arn\u00e1iz J. Mutilating purpura fulminans in an adult with meningococcal sepsis. P R Health Sci J. 2017;36(3):179\u201382.","journal-title":"P R Health Sci J"},{"key":"12795_CR74","doi-asserted-by":"publisher","first-page":"bcr2017223388","DOI":"10.1136\/bcr-2017-223388","volume":"2018","author":"T Zimmermann","year":"2018","unstructured":"Zimmermann T, Chmiel C. Neisseria meningitidis sepsis in a patient with acute epiglottitis and respiratory failure. BMJ Case Rep. 2018;2018:bcr2017223388.","journal-title":"BMJ Case Rep"},{"issue":"Suppl 1","key":"12795_CR75","first-page":"A38","volume":"13","author":"L Rosenfield","year":"2017","unstructured":"Rosenfield L, Cvetkovic A, Woodward K, Quirt J. Late presentation of possible terminal compliment deficiency with recurrent Neisseria meningitides infection. Allergy Asthma Clin Immunol. 2017;13(Suppl 1):A38.","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"1","key":"12795_CR76","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12879-018-3119-4","volume":"18","author":"A Lesourd","year":"2018","unstructured":"Lesourd A, Magne N, Soares A, Lemaitre C, Taha M-K, Gueit I, Wolff M, Caron F. Primary bacterial ventriculitis in adults, an emergent diagnosis challenge: report of a meningoccal case and review of the literature. BMC Infect Dis. 2018;18(1):226.","journal-title":"BMC Infect Dis"},{"issue":"23","key":"12795_CR77","doi-asserted-by":"publisher","first-page":"1900070","DOI":"10.2807\/1560-7917.ES.2019.24.23.1900070","volume":"24","author":"J Lawler","year":"2019","unstructured":"Lawler J, Lucidarme J, Parikh S, Smith L, Campbell H, Borrow R, Gray S, Foster K, Ladhani S. Suspected cluster of Neisseria meningitidis W invasive disease in an elderly care home: do new laboratory methods aid public health action? United Kingdom, 2015. Euro Surveill. 2019;24(23):1900070.","journal-title":"Euro Surveill"},{"issue":"44","key":"12795_CR78","doi-asserted-by":"publisher","first-page":"20308","DOI":"10.2807\/ese.17.44.20308-en","volume":"17","author":"R Puleston","year":"2012","unstructured":"Puleston R, Beck C, Tahir M, Bardhan M, Charlemagne P, Alves C, Ladhani S, Watson C, Ramsay M, Kaczmarksi E, et al. An unusual transmission event of Neisseria meningitidis serogroup W135 type 2a in a healthcare setting, England, 2012. Euro Surveill. 2012;17(44):20308.","journal-title":"Euro Surveill"},{"issue":"23","key":"12795_CR79","doi-asserted-by":"publisher","first-page":"30549","DOI":"10.2807\/1560-7917.ES.2017.22.23.30549","volume":"22","author":"A Russcher","year":"2017","unstructured":"Russcher A, Fanoy E, van Olden GDJ, Graafland AD, van der Ende A, Knol MJ. Necrotising fasciitis as atypical presentation of infection with emerging Neisseria meningitidis serogroup W (MenW) clonal complex 11, the Netherlands, March 2017. Euro Surveill. 2017;22(23):30549.","journal-title":"Euro Surveill"},{"issue":"1","key":"12795_CR80","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3201\/eid1801.110901","volume":"18","author":"SN Ladhani","year":"2012","unstructured":"Ladhani SN, Lucidarme J, Newbold LS, Gray SJ, Carr AD, Findlow J, Ramsay ME, Kaczmarski EB, Borrow R. Invasive meningococcal capsular group Y disease, England and Wales, 2007\u20132009. Emerg Infect Dis. 2012;18(1):63\u201370.","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"12795_CR81","first-page":"2550","volume":"6","author":"M Ristic","year":"2012","unstructured":"Ristic M, Seguljev Z, Petrovic V, Rajcevic S. Epidemiological charactheristics of meningococcal disease in Vojvodina (Serbia) at the beggining of 21st Century. HealthMED. 2012;6(7):2550\u20134.","journal-title":"HealthMED"},{"issue":"9","key":"12795_CR82","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s10096-014-2102-2","volume":"33","author":"P Pellegrino","year":"2014","unstructured":"Pellegrino P, Carnovale C, Perrone V, Salvati D, Gentili M, Brusadelli T, Antoniazzi S, Pozzi M, Radice S, Clementi E. Epidemiological analysis on two decades of hospitalisations for meningitis in the United States. Eur J Clin Microbiol Infect Dis. 2014;33(9):1519\u201324.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"12795_CR83","unstructured":"Meningitis progress tracker [https:\/\/www.meningitis.org\/mpt]"},{"key":"12795_CR84","unstructured":"Disease data from ECDC surveillance atlas for meningococcal disease [https:\/\/www.ecdc.europa.eu\/en\/meningococcal-disease\/surveillance-and-disease-data\/atlas]."},{"issue":"5","key":"12795_CR85","doi-asserted-by":"publisher","first-page":"e015080","DOI":"10.1136\/bmjopen-2016-015080","volume":"7","author":"A Polkowska","year":"2017","unstructured":"Polkowska A, Toropainen M, Ollgren J, Lyytik\u00e4inen O, Nuorti JP. Bacterial meningitis in Finland, 1995\u20132014: a population-based observational study. BMJ Open. 2017;7(5):e015080.","journal-title":"BMJ Open"},{"key":"12795_CR86","unstructured":"Meningococcal disease [https:\/\/www.cdc.gov\/meningococcal\/index.html]."},{"key":"12795_CR87","unstructured":"Rapport d'activite 2014 [https:\/\/www.pasteur.fr\/fr\/file\/3273\/download?token=8UaruHXt]."},{"key":"12795_CR88","unstructured":"Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Neisseria meningitidis, 2018 [https:\/\/www.cdc.gov\/abcs\/reports-findings\/survreports\/mening18.html]."},{"issue":"2","key":"12795_CR89","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.cmi.2017.06.021","volume":"24","author":"J Bodilsen","year":"2018","unstructured":"Bodilsen J, Brandt CT, Sharew A, Dalager-Pedersen M, Benfield T, Sch\u00f8nheyder HC, Nielsen H. Early versus late diagnosis in community-acquired bacterial meningitis: a retrospective cohort study. Clin Microbiol Infect. 2018;24(2):166\u201370.","journal-title":"Clin Microbiol Infect"},{"issue":"21","key":"12795_CR90","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1016\/j.vaccine.2019.04.020","volume":"37","author":"B Wang","year":"2019","unstructured":"Wang B, Santoreneos R, Giles L, Haji Ali Afzali H, Marshall H. Case fatality rates of invasive meningococcal disease by serogroup and age: a systematic review and meta-analysis. Vaccine. 2019;37(21):2768\u201382.","journal-title":"Vaccine"},{"issue":"220 Suppl 4","key":"12795_CR91","doi-asserted-by":"publisher","first-page":"S263","DOI":"10.1093\/infdis\/jiz251","volume":"220","author":"HE Reese","year":"2019","unstructured":"Reese HE, Ronveaux O, Mwenda JM, Bita A, Cohen AL, Novak RT, Fox LM, Soeters HM. Invasive meningococcal disease in Africa\u2019s meningitis belt: more than just meningitis? J Infect Dis. 2019;220(220 Suppl 4):S263\u20135.","journal-title":"J Infect Dis"},{"key":"12795_CR92","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ijid.2020.11.162","volume":"104","author":"MK Taha","year":"2020","unstructured":"Taha MK, Presa J, Serra L. A review of the epidemiology of invasive meningococcal disease and vaccination strategies in North Africa. Int J Infect Dis. 2020;104:189\u201397.","journal-title":"Int J Infect Dis"},{"key":"12795_CR93","first-page":"43","volume":"2019","author":"MM Lahra","year":"2018","unstructured":"Lahra MM, Enriquez RP, George CRR. Australian meningococcal surveillance programme annual report, 2017. Commun Dis Intell. 2018;2019:43.","journal-title":"Commun Dis Intell"},{"issue":"34","key":"12795_CR94","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1016\/j.vaccine.2016.06.018","volume":"34","author":"M Fukusumi","year":"2016","unstructured":"Fukusumi M, Kamiya H, Takahashi H, Kanai M, Hachisu Y, Saitoh T, Ohnishi M, Oishi K, Sunagawa T. National surveillance for meningococcal disease in Japan, 1999\u20132014. Vaccine. 2016;34(34):4068\u201371.","journal-title":"Vaccine"},{"issue":"19","key":"12795_CR95","doi-asserted-by":"publisher","first-page":"e6899","DOI":"10.1097\/MD.0000000000006899","volume":"96","author":"V Pomar","year":"2017","unstructured":"Pomar V, Benito N, L\u00f3pez-Contreras J, Coll P, Gurgu\u00ed M, Domingo P. Characteristics and outcome of spontaneous bacterial meningitis in patients with cancer compared to patients without cancer. Medicine (Baltimore). 2017;96(19):e6899.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"12795_CR96","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jinf.2012.10.030","volume":"66","author":"P Domingo","year":"2013","unstructured":"Domingo P, Pomar V, Benito N, Coll P. The changing pattern of bacterial meningitis in adult patients at a large tertiary university hospital in Barcelona, Spain (1982\u20132010). J Infect. 2013;66(2):147\u201354.","journal-title":"J Infect"},{"issue":"11","key":"12795_CR97","doi-asserted-by":"publisher","first-page":"e15493","DOI":"10.1371\/journal.pone.0015493","volume":"5","author":"AR Tuite","year":"2010","unstructured":"Tuite AR, Kinlin LM, Kuster SP, Jamieson F, Kwong JC, McGeer A, Fisman DN. Respiratory virus infection and risk of invasive meningococcal disease in central Ontario, Canada. PloS One. 2010;5(11):e15493.","journal-title":"PloS One"},{"issue":"Pt 11","key":"12795_CR98","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1099\/jmm.0.011312-0","volume":"58","author":"M Muscat","year":"2009","unstructured":"Muscat M, Spiteri G, Calleja N, Haider J, Gray SJ, Melillo JM, Mamo J, Cuschieri P. Invasive meningococcal disease in Malta: an epidemiological overview, 1994\u20132007. J Med Microbiol. 2009;58(Pt 11):1492\u20138.","journal-title":"J Med Microbiol"},{"issue":"3","key":"12795_CR99","first-page":"119","volume":"24","author":"E Passmore","year":"2013","unstructured":"Passmore E, Ferson MJ, Tobin S. EpiReview: meningococcal disease in NSW, 1991\u20132011: trends in relation to meningococcal C vaccination. N S W Public Health Bull. 2013;24(3):119\u201324.","journal-title":"N S W Public Health Bull"},{"issue":"10","key":"12795_CR100","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.3201\/eid2210.151935","volume":"22","author":"KS Carville","year":"2016","unstructured":"Carville KS, Stevens K, Sohail A, Franklin LJ, Bond KA, Brahmi A, Romanes F, Ong KS. Increase in meningococcal serogroup W disease, Victoria, Australia, 2013\u20132015. Emerg Infect Dis. 2016;22(10):1785\u20137.","journal-title":"Emerg Infect Dis"},{"issue":"51\u201352","key":"12795_CR101","first-page":"1048","volume":"61","author":"Centers for Disease Control and Prevention","year":"2013","unstructured":"Centers for Disease Control and Prevention. Prevention: Notes from the field: serogroup C invasive meningococcal disease among men who have sex with men - New York City, 2010\u20132012. MMWR Morb Mortal Wkly Rep. 2013;61(51\u201352):1048.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"28","key":"12795_CR102","doi-asserted-by":"publisher","first-page":"20523","DOI":"10.2807\/1560-7917.ES2013.18.28.20523","volume":"18","author":"U Marcus","year":"2013","unstructured":"Marcus U, Vogel U, Schubert A, Claus H, Baetzing-Feigenbaum J, Hellenbrand W, Wichmann O. A cluster of invasive meningococcal disease in young men who have sex with men in Berlin, October 2012 to May 2013. Euro Surveill. 2013;18(28):20523.","journal-title":"Euro Surveill"},{"issue":"4","key":"12795_CR103","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1136\/sextrans-2019-054318","volume":"96","author":"M Mart\u00edn-S\u00e1nchez","year":"2020","unstructured":"Mart\u00edn-S\u00e1nchez M, Fairley CK, Bradshaw CS, Chen MY, Chow EPF. Meningococcal vaccine uptake among men who have sex with men in response to an invasive meningococcal C disease outbreak in Melbourne Australia. Sex Transm Infect. 2020;96(4):246\u201350.","journal-title":"Sex Transm Infect"},{"key":"12795_CR104","unstructured":"Safadi MA, de Moraes J, Moraes C. A critical analysis of the epidemiologic profile of serogroup B meningococcal disease in Brazil, 2001\u20132015. 2021. https:\/\/espid2017.kenes.com\/Documents\/ESPID17%20abstracts.pdf. Accessed 25 Mar\u00a02021. In., vol. 2021; 2017."},{"key":"12795_CR105","first-page":"9287121","volume":"2019","author":"G de TrzewikoswkiLima","year":"2019","unstructured":"de TrzewikoswkiLima G, De Gaspari E. Study of the immune response in the elderly: is it necessary to develop a vaccine against Neisseria meningitidis for the aged? J Aging Res. 2019;2019:9287121.","journal-title":"J Aging Res"},{"key":"12795_CR106","doi-asserted-by":"crossref","first-page":"1 010411","DOI":"10.7189\/jogh.09.010411","volume":"9","author":"F van Kessel","year":"2019","unstructured":"van Kessel F, van den Ende C, Oordt-Speets AM, Kyaw MH. Outbreaks of meningococcal meningitis in non-African countries over the last 50 years: a systematic review. J Glob Health. 2019;9:1 010411.","journal-title":"J Glob Health"},{"issue":"1","key":"12795_CR107","doi-asserted-by":"publisher","first-page":"010409","DOI":"10.7189\/jogh.09.010409","volume":"9","author":"ME Peterson","year":"2019","unstructured":"Peterson ME, Li Y, Bita A, Moureau A, Nair H, Kyaw MH, Meningococcal Surveillance Group, Abad R, Bailey F, Garcia IF, et al. Meningococcal serogroups and surveillance: a systematic review and survey. J Glob Health. 2019;9(1):010409.","journal-title":"J Glob Health"},{"issue":"3","key":"12795_CR108","first-page":"130","volume":"80","author":"DA Cabrera-Gayt\u00e1n","year":"2017","unstructured":"Cabrera-Gayt\u00e1n DA, P\u00e9rez-P\u00e9rez GF, Arriaga-Nieto L, Vallejos-Par\u00e1s A, Padilla-Vel\u00e1zquez R, Grajales-Mu\u00f1iz C. Epidemiological surveillance of meningeal and encephalic syndrome in the Mexican social security Institute, 2012\u20132014. Rev Med Hosp Gen (Mex). 2017;80(3):130\u20138.","journal-title":"Rev Med Hosp Gen (Mex)"},{"issue":"4","key":"12795_CR109","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/cid\/ciy548","volume":"68","author":"SA Mbaeyi","year":"2019","unstructured":"Mbaeyi SA, Blain A, Whaley MJ, Wang X, Cohn AC, MacNeil JR. Epidemiology of meningococcal disease outbreaks in the United States, 2009\u20132013. Clin Infect Dis. 2019;68(4):580\u20135.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"12795_CR110","doi-asserted-by":"publisher","first-page":"e360","DOI":"10.1016\/S2589-7500(21)00077-7","volume":"3","author":"AB Brueggemann","year":"2021","unstructured":"Brueggemann AB, van JansenRensburg MJ, Shaw D, McCarthy ND, Jolley KA, Maiden MCJ, van der Linden MPG, Amin-Chowdhury Z, Bennett DE, Borrow R, et al. Changes in the incidence of invasive disease due to streptococcus pneumoniae, haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the invasive respiratory infection surveillance initiative: a prospective analysis of surveillance data. Lancet Digit Health. 2021;3(6):e360\u201370.","journal-title":"Lancet Digit Health"},{"issue":"1","key":"12795_CR111","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1186\/s13104-020-05241-9","volume":"13","author":"MK Taha","year":"2020","unstructured":"Taha MK, Deghmane AE. Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease. BMC Res Notes. 2020;13(1):399.","journal-title":"BMC Res Notes"},{"key":"12795_CR112","unstructured":"Calendario vaccinale per la vita 2019 [https:\/\/www.vaccinarsi.org\/notizie\/2019\/07\/%E2%80%8Bcalendario-vaccinale-per-la-vita-2019]."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-12795-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-022-12795-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-12795-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T05:04:21Z","timestamp":1666674261000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-022-12795-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,23]]},"references-count":112,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["12795"],"URL":"https:\/\/doi.org\/10.1186\/s12889-022-12795-9","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,23]]},"assertion":[{"value":"30 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"PO, FC and IBG are employees of Sanofi Pasteur and may hold shares in the company. SG was an employee of Sanofi Pasteur at the time of this review. KE is an employee of InScience Communications, Springer Healthcare Ltd, Chester, UK, which was contracted by Sanofi Pasteur to undertake the literature searches and provide editorial assistance.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"380"}}